NCT03026309View on ClinicalTrials.gov

PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility

UnknownOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

March 31, 2017

Primary Completion Date

March 31, 2019

Study Completion Date

March 31, 2019

Conditions
Depression
Interventions
OTHER

no intervantion

no intervention is being performed, only observational evaluations.

Sponsors
All Listed Sponsors
lead

Assuta Medical Center

OTHER

NCT03026309 - PET-MRI F-DOPA Activity in the Mesocorticolimbic System and Depressive Symptoms in the Prediction of Treatment Compatibility | Biotech Hunter | Biotech Hunter